spacer
spacer

PDBsum entry 1tkt

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase PDB id
1tkt

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
516 a.a. *
399 a.a. *
Ligands
PO4 ×3
H12
Metals
_MG
Waters ×37
* Residue conservation analysis
PDB id:
1tkt
Name: Transferase
Title: Crystal structure of HIV-1 reverse transcriptase in complex with gw426318
Structure: Pol polyproteins [reverse transcriptase], chain a. Chain: a. Fragment: p66. Engineered: yes. Pol polyproteins [reverse transcriptase], chain b. Chain: b. Fragment: p51. Engineered: yes
Source: Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2 isolate. Gene: pol. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
Biol. unit: Dimer (from PQS)
Resolution:
2.60Å     R-factor:   0.208     R-free:   0.282
Authors: A.L.Hopkins,J.Ren,D.I.Stuart,D.K.Stammers
Key ref: A.L.Hopkins et al. (2004). Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1. J Med Chem, 47, 5912-5922. PubMed id: 15537346 DOI: 10.1021/jm040071z
Date:
09-Jun-04     Release date:   07-Dec-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
516 a.a.*
Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
399 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: Chains A, B: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
Bound ligand (Het Group name = PO4)
matches with 55.56% similarity
+ diphosphate
   Enzyme class 3: Chains A, B: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: Chains A, B: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: Chains A, B: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 6: Chains A, B: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 7: Chains A, B: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/jm040071z J Med Chem 47:5912-5922 (2004)
PubMed id: 15537346  
 
 
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
A.L.Hopkins, J.Ren, J.Milton, R.J.Hazen, J.H.Chan, D.I.Stuart, D.K.Stammers.
 
  ABSTRACT  
 
We have used a structure-based approach to design a novel series of non-nucleoside inhibitors of HIV-1 RT (NNRTIs). Detailed analysis of a wide range of crystal structures of HIV-1 RT-NNRTI complexes together with data on drug resistance mutations has identified factors important for tight binding of inhibitors and resilience to mutations. Using this approach we have designed and synthesized a novel series of quinolone NNRTIs. Crystal structure analysis of four of these compounds in complexes with HIV-1 RT confirms the predicted binding modes. Members of this quinolone series retain high activity against the important resistance mutations in RT at Tyr181Cys and Leu100Ile.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
  20426868 J.M.Doolittle, and S.M.Gomez (2010).
Structural similarity-based predictions of protein interactions between HIV-1 and Homo sapiens.
  Virol J, 7, 82.  
19006142 Z.K.Sweeney, J.J.Kennedy-Smith, J.Wu, N.Arora, J.R.Billedeau, J.P.Davidson, J.Fretland, J.Q.Hang, G.M.Heilek, S.F.Harris, D.Hirschfeld, P.Inbar, H.Javanbakht, J.A.Jernelius, Q.Jin, Y.Li, W.Liang, R.Roetz, K.Sarma, M.Smith, D.Stefanidis, G.Su, J.M.Suh, A.G.Villaseñor, M.Welch, F.J.Zhang, and K.Klumpp (2009).
Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties.
  ChemMedChem, 4, 88-99.  
18936753 A.L.Hopkins (2008).
Network pharmacology: the next paradigm in drug discovery.
  Nat Chem Biol, 4, 682-690.  
18403035 X.Zhang, A.Crespo, and A.Fernández (2008).
Turning promiscuous kinase inhibitors into safer drugs.
  Trends Biotechnol, 26, 295-301.  
18205120 Y.Wang, F.E.Chen, J.Balzarini, E.De Clercq, and C.Pannecouque (2008).
Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
  Chem Biodivers, 5, 168-176.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer